Quantifying value-based determinants of drug and non-drug decision dynamics

被引:8
|
作者
Smith, Aaron P. [1 ]
Beckmann, Joshua S. [2 ]
机构
[1] Univ Kansas, Cofrin Logan Ctr Addict Res & Treatment, Lawrence, KS 66045 USA
[2] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA
关键词
Reinforcement learning; Drug; Rat; Matching; Habit; Remifentanil; Opioid; Choice; GENERALIZED MATCHING LAW; CHOICE; REMIFENTANIL; ADDICTION; COCAINE; MODELS; FOOD; DEPRIVATION; DOPAMINE; BEHAVIOR;
D O I
10.1007/s00213-021-05830-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale A growing body of research suggests that substance use disorder (SUD) may be characterized as disorders of decision making. However, drug choice studies assessing drug-associated decision making often lack more complex and dynamic conditions that better approximate contexts outside the laboratory and may lead to incomplete conclusions regarding the nature of drug-associated value. Objectives The current study assessed isomorphic (choice between identical food options) and allomorphic (choice between remifentanil [REMI] and food) choice across dynamically changing reward probabilities, magnitudes, and differentially reward-predictive stimuli in male rats to better understand determinants of drug value. Choice data were analyzed at aggregate and choice-by-choice levels using quantitative matching and reinforcement learning (RL) models, respectively. Results Reductions in reward probability or magnitude independently reduced preferences for food and REMI commodities. Inclusion of reward-predictive cues significantly increased preference for food and REMI rewards. Model comparisons revealed that reward-predictive stimuli significantly altered the economic substitutability of food and REMI rewards at both levels of analysis. Furthermore, model comparisons supported the reformulation of reward value updating in RL models from independent terms to a shared, relative term, more akin to matching models. Conclusions The results indicate that value-based quantitative choice models can accurately capture choice determinants within complex decision-making contexts and corroborate drug choice as a multidimensional valuation process. Collectively, the present study indicates commonalities in decision-making for drug and non-drug rewards, validates the use of economic-based SUD therapies (e.g., contingency management), and implicates the neurobehavioral processes underlying drug-associated decision-making as a potential avenue for future SUD treatment.
引用
收藏
页码:2047 / 2057
页数:11
相关论文
共 50 条
  • [21] Uncovering the spatio-temporal dynamics of value-based decision-making in the human brain: a combined fMRI - EEG study
    Larsen, Tobias
    O'Doherty, John P.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2014, 369 (1655)
  • [22] Depresssion, anxiety and other cognitive consequences of social isolation: Drug and non-drug treatments
    Taheri Zadeh, Zahra
    Rahmani, Shayan
    Alidadi, Fatemeh
    Joushi, Sara
    Esmaeilpour, Khadijeh
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [23] Cannabinoids and value-based decision making: Implications for neurodegenerative disorders
    Lee, Angela M.
    Oleson, Erik B.
    Diergaarde, Leontien
    Cheer, Joseph F.
    Pattij, Tommy
    BASAL GANGLIA, 2012, 2 (03) : 131 - 138
  • [24] Introduction to special issue on amygdala and value-based decision making
    Setlow, Barry
    Bizon, Jennifer L.
    BEHAVIOURAL BRAIN RESEARCH, 2023, 437
  • [25] A reinforcement learning diffusion decision model for value-based decisions
    Fontanesi, Laura
    Gluth, Sebastian
    Spektor, Mikhail S.
    Rieskamp, Joerg
    PSYCHONOMIC BULLETIN & REVIEW, 2019, 26 (04) : 1099 - 1121
  • [26] Children's value-based decision making
    Smith, Karen E.
    Pollak, Seth D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Resurgence of alcohol seeking produced by discontinuing non-drug reinforcement as an animal model of drug relapse
    Podlesnik, Christopher A.
    Jimenez-Gomez, Corina
    Shahan, Timothy A.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (04): : 369 - 374
  • [28] Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice
    Matthew J. Muelbl
    Natalie N. Nawarawong
    Patrick T. Clancy
    Catherine E. Nettesheim
    Yi Wei Lim
    Christopher M. Olsen
    Psychopharmacology, 2016, 233 : 2799 - 2811
  • [29] Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice
    Muelbl, Matthew J.
    Nawarawong, Natalie N.
    Clancy, Patrick T.
    Nettesheim, Catherine E.
    Lim, Yi Wei
    Olsen, Christopher M.
    PSYCHOPHARMACOLOGY, 2016, 233 (14) : 2799 - 2811
  • [30] Episodic Memories Predict Adaptive Value-Based Decision-Making
    Murty, Vishnu P.
    FeldmanHall, Oriel
    Hunter, Lindsay E.
    Phelps, Elizabeth A.
    Davachi, Lila
    JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL, 2016, 145 (05) : 548 - 558